Cadilla Challenges NPPA order clauses on Price Fixation of 847 formulations, DOP rejects plea Farhat Nasim27 Nov 2019 2:22 PM ISTThe footnote (b) stated, "In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturers shall...
Ipca Labs Gujarat facility red-flagged by USFDA for non-compliance with CGMP Medical Dialogues Bureau27 Nov 2019 12:10 PM ISTIpca Labs said since the manufacturing facility in Silvassa is already under USFDA import alert and presently not doing any US business, this will...
Glenmark diabetes management drug Metformin Hydrochloride ER tablets get USFDA nod Medical Dialogues Bureau27 Nov 2019 9:50 AM ISTThe product is a generic version of Glumetza 1 Extended‐Release Tablets, 500 mg and 1000 mg, of Salix Pharmaceuticals Inc, Glenmark said in a BSE...
Alembic Pharma gets USFDA nod for generic version of Rapaflo Capsules Medical Dialogues Bureau27 Nov 2019 9:40 AM ISTThe approved Silodosin Capsules are therapeutically equivalent to the reference listed drug product (RLD), Rapaflo Capsules, 4 mg and 8 mg, of...
Unichem Lab shares jump over 7 pc after USFDA nod for Atenolol tablets Medical Dialogues Bureau27 Nov 2019 9:15 AM ISTNew Delhi: Unichem Laboratories shares on Monday surged over 7 per cent after the company got approval from the US health regulator for Atenolol...
Teva Pharma, Israeli institutes sign agreement to boost drug research on cancer treatments Medical Dialogues Bureau27 Nov 2019 9:00 AM ISTA partnership with Tel Aviv University will focus on research and development in cancer and brain studies, while a collaboration with the Weizmann...
Minister informs Parliament about steps taken to promote affordable generic drugs Medical Dialogues Bureau26 Nov 2019 4:30 PM ISTNew Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
Novartis strikes USD 9.7 billion deal to acquire cholesterol drugmaker The Medicines Co Medical Dialogues Bureau26 Nov 2019 3:00 PM ISTNovartis is paying $85 per share in cash, a 24% premium over The Medicines Co's closing price of $68.55 on Friday, to acquire the U.S. biotechnology...
Indoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDA Farhat Nasim26 Nov 2019 11:30 AM ISTNew Delhi: Drug firm Indoco Remedies Ltd. recently announced the receipt of Establishment Inspection Report (EIR) for its Clinical Research...
Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal Medical Dialogues Bureau26 Nov 2019 9:30 AM ISTIn September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020 Medical Dialogues Bureau26 Nov 2019 9:28 AM ISTRoche, whose drug Risdiplam is seen as a rival for Biogen's Spinraza and Novartis's Zolgensma gene therapy, said the FDA is due to decide by May 24....
Novartis to buy biotech firm Medicines Co for about USD 7 billion: Report Medical Dialogues Bureau26 Nov 2019 9:15 AM ISTThe deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the...
